GDF15: A Hijacked Metabo-Hormone Orchestrating Cachexia and Immunosuppression in Cancer
Biomolecules · 22.07.2026 · 16 (7) · 1070
DOI: 10.3390/biom16071070 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biomolecules, online erschienen am 22.07.2026. Verfasst von Dong-Yang Qi und 2 weiteren Autor:innen. Beteiligte Einrichtung: The First Clinical Medical College, Lanzhou University, Lanzhou 730000, China. Hauptthemen laut MEDLINE: Cachexia, Growth Differentiation Factor 15, Neoplasms. Die Arbeit nennt 119 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the High-Level Talent Introduction Funds from the First Hospital of Lanzhou University.
Abstract (Originalsprache)
Cancer is responsible for systemic burdens, most notably cachexia and immunosuppression, that extend far beyond local tumor growth and collectively dictate poor outcomes. While often studied separately, these debilitating syndromes are deeply interconnected. On the basis of emerging evidence of growth differentiation factor 15 (GDF15)’s dual actions in immunity and metabolism, we propose that the stress-responsive hormone GDF15 is hijacked by tumors and repurposed as a central metaboceptive hub that integrates diverse oncogenic stress signals to launch a coordinated, dual pathological cascade. Systemically, it disrupts brain–body communication via glial cell line-derived neurotrophic factor family receptor alpha-like (GFRAL) activation in the brainstem, driving anorexia, metabolic rewiring, and progressive wasting of skeletal muscle and adipose tissue that define cachexia. GDF15 acts as a potent immunosuppressor within the local tumor microenvironment, impairing T cell cytotoxicity and increasing the abundance of regulatory T cells. Crucially, these effects are not parallel but interlinked, forming a self-reinforcing detrimental cycle that accelerates host deterioration and therapeutic failure. This positions the GDF15-GFRAL axis as a unique dual-benefit therapeutic target with the potential to simultaneously ameliorate cachexia, improve patient function and quality of life, and revitalize anti-tumor immunity. Reframing cancer through the lens of a hijacked metabolic sensing system provides an integrated perspective that transforms this formidable challenge of concurrent host wasting and immune evasion into a druggable opportunity, charting a course for novel host-directed therapies that restore systemic homeostasis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The First Clinical Medical College, Lanzhou University, Lanzhou 730000, China.
- Institute of Cancer Neuroscience, Medical Frontier Innovation Research Center, The First Hospital of Lanzhou University, The First Clinical Medical College of Lanzhou University, Lanzhou 730000, China.
ORCID-Profile: Dong-Yang Qi, Wei-Lin Jin
Förderung
- the High-Level Talent Introduction Funds from the First Hospital of Lanzhou University
Zitieren
APA
Qi, D. Y., Wang, Y. F., & Jin, W. L. (2026). GDF15: A Hijacked Metabo-Hormone Orchestrating Cachexia and Immunosuppression in Cancer. Biomolecules, 16(7), 1070. https://doi.org/10.3390/biom16071070
Vancouver
Qi DY, Wang YF, Jin WL. GDF15: A Hijacked Metabo-Hormone Orchestrating Cachexia and Immunosuppression in Cancer. Biomolecules. 2026;16(7):1070. doi:10.3390/biom16071070
BibTeX
@article{Qi2026,
author = {Qi, Dong-Yang and Wang, Yong-Fei and Jin, Wei-Lin},
title = {GDF15: A Hijacked Metabo-Hormone Orchestrating Cachexia and Immunosuppression in Cancer},
journal = {Biomolecules},
year = {2026},
volume = {16},
number = {7},
pages = {1070},
doi = {10.3390/biom16071070}
}
EUVIMED